Reality star Savannah Chrisley found herself under the federal spotlight recently after the U.S. Food and Drug Administration (Fda) took issue with the wording on her weight-loss medicine website. According to TMZ, the Fda sent a warning letter to the Unlocked podcast host last month, listing several issues they found in a review of her website, GoodGirlRX.com. Founded by Savannah, GoodGirlRX is described as a “wellness company” that provides “science-backed care designed to support the way women actually live.” The main issue the Fda took issue with was the claims regarding the Glp-1 products advertised on the website, particularly those containing semaglutide and tirzepatide. Per the Cleveland Clinic,…
‘ The preceding article may include information circulated by third parties ’
‘ Some details of this article were extracted from the following source www.imdb.com ’
ADVERTISEMENT
